DISCUSSION BOARD
      PANEL DE DISCUSION
        Quality of life (QoL): benefits of early anemia treatment

          Fernando Valderrábano Quintana
          Hospital General Universitario Gregorio Marańón,
          Madrid, Spain.

        In evaluating outcomes in end-stage renal disease (ESRD), as well as in other chronic diseases, QoL has become as important as morbidity and mortality. It is also a valuable parameter in the evaluation of treatment effectiveness and cost-profit analysis. QoL according to the WHO definition is not only the absence of disease, but the presence of physical, mental and social well-being.


        There are different instruments to analyze the patient perception of the physical, psychological and social domains of health. These instruments may be non-specific or disease-specific. Non-specific instruments have been widely used in evaluating QoL in different chronic diseases as well as in ESRD, such as the Sickness Impact Profile (SIP) and more recently the SF-36. The Kidney Disease Quality of Life (KDQOL) test and its short form KDQOL-SF are specific tests developed for ESRD patients.


        Several factors influence QoL in ESRD patients. After the introduction of epoetin treatment, several studies demonstrated a significant improvement in QoL of dialysis and pre-dialysis patients. The hemoglobin level achieved after epoetin therapy has a close relationship to QoL scores. The higher the hemoglobin level, the better the QoL. Other factors related to better QoL are the socio-economic level and the level of education. However, older age, comorbidity, diabetes and female sex are related to a worse QoL.


        In pre-dialysis patients, epoetin treatment significantly improves QoL, allowing the patient to maintain a situation of well-being until starting dialysis. It has been shown that QoL in pre-dialysis patients deteriorates in relation to the decrease of GFR, and a worse QoL is also related to a late referral of the patient to the nephrologist. Older age, co-morbidity, female sex, poor educational level and unemployment are other factors with a negative influence in QoL. Recent studies show that QoL is a prognostic factor of survival. ESRD patients with low QoL have a higher mortality than those perceiving a good QoL.


        Early treatment of anemia in ESRD patients is the best way to maintain an adequate QoL in the pre-dialysis and dialysis phase, and is associated to a good survival rate. 


        Image 1 Image 2 Image 3 Image 4 Image 5
        Image 6 Image 7 Image 8 Image 9 Image 10
        Image 11 Image 12 Image 13 Image 14 Image 15
        Image 16 Image 17 Image 18 Image 19 Image 20
        Image 21 Image 22 Image 23 Image 24 Image 25
        Image 26 Image 27 Image 28 Image 29 Image 30
        Image 31 Image 32 Image 33 Image 34 Image 35
        Image 36 Image 37 Image 38 Image 39 Image 40


            DISCUSSION BOARD
            PANEL DE DISCUSION